GNH USA

Europe — EMA

Monroltec (Sodium Molybdate (99mo))

GNH USA supplies Monroltec (Sodium Molybdate), a radiopharmaceutical for diagnostic imaging such as bone, cardiac and renal scans.

Sodium Molybdate (99mo)

Request sourcing

1
Pack/s

What is Sodium Molybdate (99mo)?

Sodium Molybdate, the active ingredient in Monroltec, is a radiopharmaceutical presented as a sterile solution for intravenous or ocular use. It provides a source of technetium‑99m for gamma‑camera imaging in diagnostic procedures.

GNH USA supplies Monroltec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

What is Sodium Molybdate (99mo) used for?

Monroltec is used in nuclear medicine to generate technetium‑99m for imaging of specific organ systems. - Bone scintigraphy: enables visualization of skeletal metabolism and detection of metastases. - Cardiac perfusion imaging: assesses myocardial blood flow and identifies ischemic regions. - Renal function imaging: evaluates renal perfusion and excretory function using dynamic scans.

What are the side effects of Sodium Molybdate (99mo)?

Monroltec may cause a range of adverse reactions following administration.

Common Side Effects: - Injection site pain: mild discomfort at the site of IV or ocular delivery. - Flushing: transient redness and warmth. - Nausea: occasional mild gastrointestinal upset. - Headache: brief, self‑limiting. - Mild allergic reaction: rash or itching. - Transient hypotension: brief drop in blood pressure.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic response requiring immediate medical attention. - Severe hypotension: prolonged low blood pressure. - Radiation‑induced skin injury: localized erythema at injection site. - Organ toxicity: rare renal or hepatic impairment. - Hematologic effects: transient changes in blood counts. - Severe allergic reaction: bronchospasm or angioedema.

What precautions apply to Sodium Molybdate (99mo)?

Before using Monroltec, clinicians should consider several safety measures. - Verify patient identity: confirm correct patient and indication. - Assess renal function: ensure adequate clearance for imaging agents. - Review allergy history: check for prior reactions to radiopharmaceuticals. - Ensure radiopharmacy compliance: follow GMP and shielding protocols. - Monitor vital signs: observe blood pressure and heart rate during and after administration. - Store at ambient temperature: keep in original shielding container, protect from light and moisture.

What does Sodium Molybdate (99mo) interact with?

Monroltec may interact with other agents that influence radionuclide uptake or distribution.

Major Interactions (Avoid): - Iodine‑containing contrast agents: can interfere with technetium uptake and image quality. - Antithyroid medications: may alter thyroid imaging results. - Strong chelating agents (e.g., DTPA): bind technetium and reduce diagnostic efficacy.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may affect cardiac perfusion imaging interpretation. - Diuretics: can modify renal scan dynamics. - Calcium supplements: may compete with bone‑seeking tracers. - Thyroid hormone therapy: influences thyroid uptake studies. - Certain antibiotics (e.g., sulfonamides): may cause mild alterations in biodistribution.

Frequently asked questions

What is Monroltec used for?+
Monroltec is a radiopharmaceutical that provides molybdenum‑99, which decays to technetium‑99m. The resulting technetium‑99m is used in gamma‑camera imaging for diagnostic procedures such as bone scans, cardiac perfusion studies, and renal function assessments.
How does sodium molybdate work in Monroltec?+
Sodium molybdate acts as a generator of the isotope molybdenum‑99. After administration, Mo‑99 decays to technetium‑99m, a gamma‑emitting radionuclide that can be attached to specific imaging kits, allowing targeted visualization of organs or tissues with a gamma camera.
What is the usual dose of Monroltec?+
The dose of Monroltec is determined by the prescribing physician or nuclear medicine specialist based on the specific imaging protocol, patient characteristics, and the intended diagnostic study. No standard dosing regimen is provided here.
Is Monroltec safe to use during pregnancy or breastfeeding?+
The safety of Monroltec in pregnancy or lactation has not been fully established. Use is generally avoided unless the diagnostic benefit outweighs potential risks, and decisions should be made by the treating physician in consultation with the patient.
How do I order Monroltec from GNH USA?+
To order Monroltec, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.
How does Monroltec compare with other technetium‑99m generators?+
Monroltec (sodium molybdate) is a molybdenum‑99 generator similar to other commercially available generators. Its performance, purity and radiochemical yield are comparable, but specific differences may exist in formulation, shelf‑life, and regulatory status, which should be evaluated by the purchasing institution.
What are the storage and handling requirements for Monroltec?+
Monroltec should be stored at ambient temperature, protected from light and moisture, and kept in its original shielding container. Follow all radiopharmacy safety guidelines, and avoid freezing or shaking the product.
How is Monroltec administered to patients?+
Monroltec is administered by a qualified healthcare professional either intravenously or via ocular injection, depending on the intended imaging study. Proper aseptic technique and radiation safety precautions must be observed during administration.
What are the most serious risks associated with Monroltec?+
Serious risks include severe allergic reactions such as anaphylaxis, significant hypotension, radiation‑induced skin injury at the injection site, and rare organ toxicity. Immediate medical attention is required if any of these events occur.
Who should not use Monroltec?+
Monroltec should not be used in patients with known hypersensitivity to sodium molybdate or any component of the formulation, in individuals with uncontrolled severe hypotension, or in situations where the diagnostic benefit does not outweigh the potential radiation exposure.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Sodium Molybdate (99mo)
Route
Intravenous Use , Ocular Use
Manufacturer
Monrol Europe Srl
Origin
EU

Related products

Montek

Montek

Sodium Molybdate (99mo)

Monrol Europe Srl
EU
Montek

Montek

Sodium Molybdate (99mo)

Monrol Europe Srl
EU
Montek

Montek

Sodium Molybdate (99mo)

Monrol Europe Srl
EU
Montek

Montek

Sodium Molybdate (99mo)

Monrol Europe Srl
EU